| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 02/25/2014 | US8658654 Receptor-type kinase modulators and methods of use |
| 02/25/2014 | US8658650 Substituted 1,1,3,1-tetraoxidobenzo[D][1,3,2]dithiazoles as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| 02/25/2014 | US8658639 N-substituted-cyclic amino derivative |
| 02/25/2014 | US8658635 Benzpyrazol derivatives as inhibitors of PI3 kinases |
| 02/25/2014 | CA2777632C Imidazole derivatives as casein kinase inhibitors |
| 02/25/2014 | CA2593439C Thiazole-4-carboxamide derivatives as mglur5 antagonists |
| 02/22/2014 | CA2787472A1 Protein kinase inhibitors |
| 02/20/2014 | WO2014028803A1 Substituted pyrazoles as n-type calcium channel blockers |
| 02/20/2014 | WO2014028459A1 1,4-disubstituted pyridazine analogs and methods for treating smn-deficiency-related conditions |
| 02/20/2014 | WO2014028025A1 Compositions and methods for treating myotonic dystrophy type 1 |
| 02/20/2014 | WO2014027873A1 Preparation of novel modified chitosan/clay bio-composites |
| 02/20/2014 | WO2014026997A1 2,3-benzodiazepines |
| 02/20/2014 | WO2013186726A3 Multicomponent crystals comprising dasatinib and selected cocrystal formers |
| 02/20/2014 | WO2012145617A9 Aminopyrimidine kinase inhibitors |
| 02/20/2014 | US20140051857 Heterocyclic compounds and thrombopoietin receptor activators |
| 02/20/2014 | US20140051729 Compositions and methods for treating degenerative muscle conditions |
| 02/20/2014 | US20140051711 Compounds that modulate intracellular calcium |
| 02/20/2014 | US20140051709 Compositions and Methods for Treating Myotonic Dystrophy Type 1 |
| 02/20/2014 | US20140051702 Use of Aminoindane Compounds in Treating Overactive Bladder and Interstitial Cystitis |
| 02/20/2014 | US20140051682 Novel 1,2- bis-sulfonamide derivatives as chemokine receptor modulators |
| 02/20/2014 | US20140051681 Mst1 kinase inhibitors and methods of their use |
| 02/20/2014 | US20140051676 Triazine-oxadiazoles |
| 02/20/2014 | US20140051672 1,4-disubstituted pyridazine analogs there of and methods for treating smn-deficiency-related conditions |
| 02/20/2014 | US20140050699 Heterocyclic inhibitors of glutaminase |
| 02/19/2014 | EP2698835A1 Compound with branching alkyl-chains, method for preparing the same, and use thereof in photoelectric device |
| 02/19/2014 | EP2698369A1 Benzopyrone derivative and use thereof |
| 02/19/2014 | EP2698368A1 Novel pyrazole derivative |
| 02/19/2014 | EP2697240A1 Glycoside derivatives and uses thereof |
| 02/19/2014 | EP2697220A1 Chromenone compounds as pi 3 -kinase inhibitors for the treatment of cancer |
| 02/19/2014 | EP2697210A1 5-substituted iminothiazines and their mono-and dioxides as bace inhibitors, compositions, and their use |
| 02/19/2014 | EP2697209A1 Method for the preparation of substituted oxazolidinones |
| 02/19/2014 | EP2697206A1 Heterocyclic compounds and uses thereof in the treatment of sexual disorders |
| 02/19/2014 | EP2697199A1 Aryl-or heteroaryl-substituted benzene compounds |
| 02/19/2014 | EP2696688A1 Use of substituted dithiine-dicarboximides for combating phytopathogenic fungi |
| 02/19/2014 | CN103596948A Chromenone compounds as PI 3-kinase inhibitors for the treatment of cancer |
| 02/19/2014 | CN103596945A N-(1,2,5-oxadiazol-3-yl)-, n-(tetrazol-5-yl)- and n-(triazol-5-yl)bicycloarylcarboxamides and their use as herbicides |
| 02/19/2014 | CN103596939A 5-substituted iminothiazines and their mono-and dioxides as BACE inhibitors, compositions, and their use |
| 02/19/2014 | CN103596938A 噻唑衍生物 Thiazole derivatives |
| 02/19/2014 | CN103596936A Herbicidally and fungicidally active 3-phneylisoxazoline-5-carboxamides and 3-phneylisoxazoline-5-thioamides |
| 02/19/2014 | CN103596929A Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators |
| 02/19/2014 | CN103596926A Fused tricyclic compounds as RAF kinase inhibitors |
| 02/19/2014 | CN103588770A 1,2,4-thiadiazole derivatives and their use as electroluminescent materials |
| 02/19/2014 | CN103588769A Synthesis of novel dihydrogen pyrazole-thiazolinone derivatives and application of dihydrogen pyrazole-thiazolinone derivatives in anticancer drugs |
| 02/19/2014 | CN103588768A Use of furan nucleus-containing 2,5-disubstituted-1,3,4-thiadiazole compound in preparation of phytophthora infestans inhibitor |
| 02/19/2014 | CN103588767A Preparation method of dabrafenib |
| 02/19/2014 | CN103588718A Novel triazinedione derivatives as GABAB receptor modulators |
| 02/19/2014 | CN103588713A Multi-target ubenimex prodrug derivative, as well as preparation method and application thereof |
| 02/19/2014 | CN103588704A Inhibitors of focal adhesion kinase |
| 02/19/2014 | CN101696977B Method for determining stage of neurofibrillary degeneration |
| 02/18/2014 | US8653279 Dye for dye-sensitized solar cell, and solar cell prepared from same |
| 02/18/2014 | US8653272 Fused pyridine derivatives as kinase inhibitors |
| 02/18/2014 | US8653263 Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators |
| 02/18/2014 | US8653082 6-phenyl-2-[((piperidin-4-ylmethyl)-piperazin-1YL) or piperazin 1-ylmethyl)-piperidin-1-yl)]-imidazo[2,1-B][1,3,4]thiadiazole derivatives and their use |
| 02/18/2014 | US8653067 Pharmaceutical composition for treating Alzheimer's disease |
| 02/18/2014 | US8653062 Compounds as receptor modulators with therapeutic utility |
| 02/18/2014 | CA2701594C Heterocycle phenyl amide t-type calcium channel antagonists |
| 02/18/2014 | CA2577061C Histamine h3 receptor agents, preparation and therapeutic uses |
| 02/18/2014 | CA2564076C Chemical linkers and conjugates thereof |
| 02/18/2014 | CA2563831C Monocyclic heterocycles as kinase inhibitors |
| 02/13/2014 | WO2014026039A2 Aryl-and heteroaryl-substituted benzene derivatives as modulators of pi3-kinase signalling pathways |
| 02/13/2014 | WO2014026009A2 Inhibition of antimicrobial targets with reduced potential for resistance |
| 02/13/2014 | WO2014025976A1 Heteroaromatic compounds as bruton's tyrosine kinase (btk) inhibitors |
| 02/13/2014 | WO2014025706A1 Sweet flavor modifier |
| 02/13/2014 | WO2014023814A1 New antibacterial compounds |
| 02/13/2014 | WO2014023754A1 Compounds for use in the treatment of disorders that are ameliorated by inhibition of hdac |
| 02/13/2014 | US20140045862 Cycloalkane Derivatives |
| 02/13/2014 | US20140045861 Compounds for inflammation and immune-related uses |
| 02/13/2014 | US20140045859 Glucokinase Activators |
| 02/13/2014 | US20140045854 Methods and Compositions for the Treatment of Cancer and Related Hyperproliferative Disorders |
| 02/13/2014 | US20140045850 Inhibitors of histone deacetylase |
| 02/13/2014 | US20140045829 Substituted 1,3-benzothiazol-2(3h)-ones and [1,3]thiazolo[5,4-b]pyridin-2(1h)-ones as positive allosteric modulators of mglur2 |
| 02/13/2014 | US20140045813 Heteroaromatic compounds as btk inhibitors |
| 02/13/2014 | US20140045811 Amide, urea or sulfone amide linked benzothiazole inhibitors of endothelial lipase |
| 02/13/2014 | US20140045802 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use |
| 02/12/2014 | EP2694499A1 Process for the preparation of an antipsychotic agent |
| 02/12/2014 | EP2694495A1 1,4-oxazepines as bace1 and/or bace2 inhibitors |
| 02/12/2014 | EP2694494A1 Fungicide hydroximoyl-tetrazole derivatives |
| 02/12/2014 | EP2694491A1 Benzodioxepine and benzodioxine compounds that interact with glucokinase regulatory protein for the treatment of diabetes |
| 02/12/2014 | EP2694482A1 Wnt pathway antagonists |
| 02/12/2014 | EP2694481A1 Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents |
| 02/12/2014 | EP2694479A1 Process for the preparation of an hiv integrase inhibitor |
| 02/12/2014 | EP2694476A1 Inhibitors of viral replication, their process of preparation and their therapeutical uses |
| 02/12/2014 | EP2694059A2 Small molecule inhibitors of xbp1 splicing |
| 02/12/2014 | EP2693882A1 Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment |
| 02/12/2014 | CN103582637A Inhibitors of bruton's tyrosine kinase |
| 02/12/2014 | CN103579528A Electronic transfer layer, organic light-emitting device comprising electronic transfer layer and manufacturing method of organic light-emitting device |
| 02/12/2014 | CN103570729A Bicyclic neonicotine compounds constructed by cycloalkenone, and preparation method and application thereof |
| 02/12/2014 | CN103570707A Improved synthetic method of aztreonam |
| 02/12/2014 | CN103570706A Antibacterial compound containing quinoline or pyrazole heterocycle rhodanine structure |
| 02/12/2014 | CN103570693A Bridged compound serving as hepatitis C inhibitor and application of bridged compound in medicines |
| 02/12/2014 | CN103570683A Multi-substituted amine compound, as well as preparation method and use thereof |
| 02/12/2014 | CN103570642A Isothiazolinone compound and application thereof as bactericide |
| 02/12/2014 | CN103570630A Heterocyclic nitrogen derivative and application thereof in medicines |
| 02/12/2014 | CN102372681B Environment-friendly thiazole compound as well as preparation and application thereof |
| 02/12/2014 | CN102127065B Ortho-heterocyclic formyl substituted aniline compound as well as synthetic method and application thereof |
| 02/12/2014 | CN101463031B Indazole and tetrahydrochysene indazole compounds, and preparation, pharmaceutical composition and use thereof |
| 02/11/2014 | US8648206 Light-activated actuator element |
| 02/11/2014 | US8648069 5-substituted indazoles as kinase inhibitors |
| 02/11/2014 | CA2738563C 8-substituted isoquinoline derivatives and the use thereof |
| 02/11/2014 | CA2681572C Inhibitors of ion channels |